Cargando…
A Perspective on Newly Emerging Proteolysis-Targeting Strategies in Antimicrobial Drug Discovery
Targeted protein degradation is a new aspect in the field of drug discovery. Traditionally, developing an antibiotic includes tedious and expensive processes, such as drug screening, lead optimization, and formulation. Proteolysis-targeting chimeras (PROTACs) are new-generation drugs that use the pr...
Autores principales: | Venkatesan, Janarthanan, Murugan, Dhanashree, Rangasamy, Loganathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774230/ https://www.ncbi.nlm.nih.gov/pubmed/36551374 http://dx.doi.org/10.3390/antibiotics11121717 |
Ejemplares similares
-
A perspective to weaponize microRNAs against lung cancer
por: Murugan, Dhanashree, et al.
Publicado: (2022) -
Pooled evidence from preclinical and clinical studies for stem cell-based therapy in ARDS and COVID-19
por: Murugan, Dhanashree, et al.
Publicado: (2022) -
Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy
por: Murugan, Dhanashree, et al.
Publicado: (2022) -
Can 3D-Printed Bioactive Glasses Be the Future of Bone Tissue Engineering?
por: Dukle, Amey, et al.
Publicado: (2022) -
Emerging Strategies in Proteolysis-Targeting Chimeras (PROTACs): Highlights from 2022
por: Tamatam, Rekha, et al.
Publicado: (2023)